Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Brazil
Empagliflozin

Anvisa 2026

Empagliflozin, Linagliptin

empagliflozina + linagliptina

BrazilAuthorisedAuthorised 21 Sept 2026

Ask Osler about it

On this page

In other countries
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

GlyxambiEuropean Union · Boehringer Ingelheim International GmbHSame form
GlyxambiCroatiaSame form
GlyxambiSaudi Arabia · Boehringer Ingelheim Pharma GmbH & Co. KGSame form
GlyxambiCanada · 25 MG + 5 MG · Tablet · Boehringer Ingelheim (Canada) LTD LteeSame substance
GlyxambiCanada · 10 MG + 5 MG · Tablet · Boehringer Ingelheim (Canada) LTD LteeSame substance
Glyxambi 10 MG/5 MG Comprimidos Recubiertos con PeliculaSpain · 10 mg + 5 mg · comprimido recubierto con película · Boehringer Ingelheim International GmbhSame substance
Glyxambi 25 MG/5 MG Comprimidos Recubiertos con PeliculaSpain · 25 mg + 5 mg · comprimido recubierto con película · Boehringer Ingelheim International Gmbh

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Same substance

🇮🇹GlyxambiItaly · Compressa rivestita con film · Boehringer Ingelheim International GMBHSame substance

🇳🇱Glyxambi 10 mg/ 5 mg, filmomhulde tablettenNetherlands · Filmomhulde tablet · Boehringer Ingelheim International GmbHSame substance

🇳🇱Glyxambi 25 mg/ 5 mg, filmomhulde tablettenNetherlands · Filmomhulde tablet · Boehringer Ingelheim International GmbHSame substance

🇸🇬Glyxambi Film-Coated Tablets 10 MG/5 MGSingapore · 10.00 mg + 5.00 mg · tablet, film coated · Boehringer Ingelheim Singapore Pte. LTD.Same substance

🇸🇬Glyxambi Film-Coated Tablets 25 MG/5 MGSingapore · 25.00 mg + 5.00 mg · tablet, film coated · Boehringer Ingelheim Singapore Pte. LTD.Same substance

🇺🇸GlyxambiUnited States · 10MG; 5MG, 25MG; 5MG · tablet · Boehringer IngelheimSame substance

🇺🇸Empagliflozin and LinagliptinUnited States · 10MG; 5MG, 25MG; 5MG · tablet · Prinston Pharma INCSame substance

🇺🇸Empagliflozin; LinagliptinUnited States · 10MG; 5MG, 10MG/5MG, 25MG; 5MG … · tablet · Annora PharmaSame substance

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Empagliflozin, Linagliptin
Register: Brazil (Anvisa)
Status: Authorised
Status in the register: Ativo
Authorised: 21 Sept 2026
Registration: 102351486
Marketing authorisation holder: Ems S/A
Procedure: Registered